| abstract |
The present invention relates to compounds having the formula (I), and to its pharmaceutically acceptable salt: from to Ar, r, Y, Z, Q, W, X, and R 5 are defined herein -7 Respectively. These compounds have AT 1 receptor antagonist activity and neprilysin inhibitory activity. The present invention also relates to pharmaceutical compositions comprising such compounds; Methods of using such compounds; And to methods and intermediates for preparing such compounds. |